Trial record 1 of 1 for:    NCT00692770
Previous Study | Return to List | Next Study

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00692770
First received: June 5, 2008
Last updated: March 17, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2020
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
No publications provided by Bayer

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):